MK0633

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MK0633, covering 2015-06-01 to 2015-10-20. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of MK0633 in Patients With Chronic Asthma (0633-007) [Phase 2]